探索“互联网+医联体”糖尿病管理新路径——中西医结合代谢性疾病(糖尿病)标准化管理项目在京启动

2020-12-17 动脉网 动脉网

2020年12月10日,北京中医药大学糖尿病研究中心牵头发起的中西医结合代谢性疾病(糖尿病)标准化管理项目在京正式启动,标志着“互联网+医联体”模式下中西医结合糖尿病标准化管理进入全新的发展阶段,是践

2020年12月10日,北京中医药大学糖尿病研究中心牵头发起的中西医结合代谢性疾病(糖尿病)标准化管理项目在京正式启动,标志着“互联网+医联体”模式下中西医结合糖尿病标准化管理进入全新的发展阶段,是践行健康中国行动、落实中医药传承创新发展战略的一项重要工作。

(中西医结合代谢性疾病(糖尿病)标准化管理项目启动仪式)

北京市中医管理局科教处处长王会玲、北京市东城区委卫生健康工作委员会书记、东城区卫生健康委员会主任王建辉、北京中医药大学中医学院院长李峰、北京中医药大学招生就业处副处长宋萌等出席活动并发表了讲话,清华大学玉泉医院冯兴中教授、北京中医药大学东直门医院杨晓晖教授、王世东教授、北京市和平里医院吴春军院长、贺仲晨教授等专家学者,以及阿里健康、京东健康、康爱多、九州通、心医国际等互联网医院平台、医联体服务平台参加了启动仪式。

(北京市中医管理局科教处处长王会玲)

(北京市东城区委卫生健康工作委员会书记、东城区卫生健康委员会主任王建辉)

在后疫情时代,基于医疗大数据的分级诊疗和互联网医疗快速发展,尤其在有庞大患者人群的糖尿病等慢病管理领域,已经成为受到学界和产业界普遍关注的热点。在“互联网+医联体”模式下,如何推进中医药科技创新成果的转化应用、提升中西医结合糖尿病管理标准化水平,是新形势下中西医结合代谢性疾病学科发展面临的一个重要课题。中西医结合代谢性疾病(糖尿病)标准化管理项目由北京中医药大学糖尿病研究中心牵头发起,依托、联合行业专家、学术组织、平台机构,共同探索制定“互联网+医联体”模式下的中西医结合糖尿病管理标准;委托北京中医药大学双创平台,实现标准化管理方案的应用推广、加速中医药科技创新成果的转化;建设临床转化基地和基层医疗中心,打造“统一标准、优质服务、中医药特色突出”的中西医结合防治糖尿病及相关疾病的诊疗和健康管理中心;构建高效连接医、患、药以及智能硬件的糖尿病管理大数据网络,开展中医药真实世界研究;开展中国式生活方式干预糖尿病管理的相关研究。

(北京中医药大学中医学院院长李峰)

(北京中医药大学招生就业处副处长宋萌)

项目启动仪式由东直门医院副院长龚燕冰教授主持,糖尿病研究中心主任高思华教授致欢迎辞,中心副研究员赵丹丹作了项目介绍。专家和平台机构代表踊跃发言,气氛热烈,并现场向各位项目指导专家颁发了聘书。会议的最后,高思华教授总结发言,宣布中西医结合代谢性疾病(糖尿病)标准化管理项目正式启动。

(北京中医药大学糖尿病研究中心主任高思华教授宣布项目启动)

(北京中医药大学糖尿病研究中心赵丹丹副研究员介绍项目情况)

(为项目指导专家颁发聘书)

该项目作为双创项目、科技成果转化项目、健联体服务项目,得到了北京中医药大学、北京市中医管理局及东城区卫健委各级领导的大力支持。通过项目实施,未来有望形成一套“稳定的、可持续发展的、有高质量输出、有评价及反馈功能”的中西医结合代谢性疾病(糖尿病)标准化管理体系,提升数据互联时代下全社会的糖尿病管理水平。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1989602, encodeId=20f3198960245, content=<a href='/topic/show?id=5e202543023' target=_blank style='color:#2F92EE;'>#代谢性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25430, encryptionId=5e202543023, topicName=代谢性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Fri Sep 24 08:16:16 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758869, encodeId=d45f1e5886986, content=<a href='/topic/show?id=9fb76191944' target=_blank style='color:#2F92EE;'>#标准化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61919, encryptionId=9fb76191944, topicName=标准化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86337383877, createdName=108807375_62823139, createdTime=Tue Aug 10 19:16:16 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931717, encodeId=c0c51931e17df, content=<a href='/topic/show?id=1a76e6753b9' target=_blank style='color:#2F92EE;'>#糖尿病管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76753, encryptionId=1a76e6753b9, topicName=糖尿病管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Thu May 13 20:16:16 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797208, encodeId=4efd1e97208b1, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Apr 14 22:16:16 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274352, encodeId=6c8112e4352f1, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335762, encodeId=a2061335e62f9, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438109, encodeId=5670143810951, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463103, encodeId=796e14631036b, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909059, encodeId=fa1a909059ef, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201216/acc2e79e3d994937861d94277f3d24b8/1a3c32dcdcc04ef8bcb0e505743f6c57.jpg, createdBy=73805409111, createdName=ms9000000194445124, createdTime=Fri Dec 18 09:38:36 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043433, encodeId=3a61104343309, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Dec 17 15:16:16 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2021-09-24 sodoo
  2. [GetPortalCommentsPageByObjectIdResponse(id=1989602, encodeId=20f3198960245, content=<a href='/topic/show?id=5e202543023' target=_blank style='color:#2F92EE;'>#代谢性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25430, encryptionId=5e202543023, topicName=代谢性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Fri Sep 24 08:16:16 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758869, encodeId=d45f1e5886986, content=<a href='/topic/show?id=9fb76191944' target=_blank style='color:#2F92EE;'>#标准化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61919, encryptionId=9fb76191944, topicName=标准化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86337383877, createdName=108807375_62823139, createdTime=Tue Aug 10 19:16:16 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931717, encodeId=c0c51931e17df, content=<a href='/topic/show?id=1a76e6753b9' target=_blank style='color:#2F92EE;'>#糖尿病管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76753, encryptionId=1a76e6753b9, topicName=糖尿病管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Thu May 13 20:16:16 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797208, encodeId=4efd1e97208b1, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Apr 14 22:16:16 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274352, encodeId=6c8112e4352f1, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335762, encodeId=a2061335e62f9, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438109, encodeId=5670143810951, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463103, encodeId=796e14631036b, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909059, encodeId=fa1a909059ef, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201216/acc2e79e3d994937861d94277f3d24b8/1a3c32dcdcc04ef8bcb0e505743f6c57.jpg, createdBy=73805409111, createdName=ms9000000194445124, createdTime=Fri Dec 18 09:38:36 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043433, encodeId=3a61104343309, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Dec 17 15:16:16 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1989602, encodeId=20f3198960245, content=<a href='/topic/show?id=5e202543023' target=_blank style='color:#2F92EE;'>#代谢性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25430, encryptionId=5e202543023, topicName=代谢性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Fri Sep 24 08:16:16 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758869, encodeId=d45f1e5886986, content=<a href='/topic/show?id=9fb76191944' target=_blank style='color:#2F92EE;'>#标准化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61919, encryptionId=9fb76191944, topicName=标准化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86337383877, createdName=108807375_62823139, createdTime=Tue Aug 10 19:16:16 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931717, encodeId=c0c51931e17df, content=<a href='/topic/show?id=1a76e6753b9' target=_blank style='color:#2F92EE;'>#糖尿病管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76753, encryptionId=1a76e6753b9, topicName=糖尿病管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Thu May 13 20:16:16 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797208, encodeId=4efd1e97208b1, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Apr 14 22:16:16 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274352, encodeId=6c8112e4352f1, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335762, encodeId=a2061335e62f9, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438109, encodeId=5670143810951, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463103, encodeId=796e14631036b, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909059, encodeId=fa1a909059ef, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201216/acc2e79e3d994937861d94277f3d24b8/1a3c32dcdcc04ef8bcb0e505743f6c57.jpg, createdBy=73805409111, createdName=ms9000000194445124, createdTime=Fri Dec 18 09:38:36 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043433, encodeId=3a61104343309, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Dec 17 15:16:16 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1989602, encodeId=20f3198960245, content=<a href='/topic/show?id=5e202543023' target=_blank style='color:#2F92EE;'>#代谢性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25430, encryptionId=5e202543023, topicName=代谢性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Fri Sep 24 08:16:16 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758869, encodeId=d45f1e5886986, content=<a href='/topic/show?id=9fb76191944' target=_blank style='color:#2F92EE;'>#标准化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61919, encryptionId=9fb76191944, topicName=标准化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86337383877, createdName=108807375_62823139, createdTime=Tue Aug 10 19:16:16 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931717, encodeId=c0c51931e17df, content=<a href='/topic/show?id=1a76e6753b9' target=_blank style='color:#2F92EE;'>#糖尿病管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76753, encryptionId=1a76e6753b9, topicName=糖尿病管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Thu May 13 20:16:16 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797208, encodeId=4efd1e97208b1, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Apr 14 22:16:16 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274352, encodeId=6c8112e4352f1, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335762, encodeId=a2061335e62f9, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438109, encodeId=5670143810951, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463103, encodeId=796e14631036b, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909059, encodeId=fa1a909059ef, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201216/acc2e79e3d994937861d94277f3d24b8/1a3c32dcdcc04ef8bcb0e505743f6c57.jpg, createdBy=73805409111, createdName=ms9000000194445124, createdTime=Fri Dec 18 09:38:36 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043433, encodeId=3a61104343309, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Dec 17 15:16:16 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1989602, encodeId=20f3198960245, content=<a href='/topic/show?id=5e202543023' target=_blank style='color:#2F92EE;'>#代谢性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25430, encryptionId=5e202543023, topicName=代谢性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Fri Sep 24 08:16:16 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758869, encodeId=d45f1e5886986, content=<a href='/topic/show?id=9fb76191944' target=_blank style='color:#2F92EE;'>#标准化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61919, encryptionId=9fb76191944, topicName=标准化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86337383877, createdName=108807375_62823139, createdTime=Tue Aug 10 19:16:16 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931717, encodeId=c0c51931e17df, content=<a href='/topic/show?id=1a76e6753b9' target=_blank style='color:#2F92EE;'>#糖尿病管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76753, encryptionId=1a76e6753b9, topicName=糖尿病管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Thu May 13 20:16:16 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797208, encodeId=4efd1e97208b1, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Apr 14 22:16:16 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274352, encodeId=6c8112e4352f1, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335762, encodeId=a2061335e62f9, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438109, encodeId=5670143810951, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463103, encodeId=796e14631036b, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909059, encodeId=fa1a909059ef, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201216/acc2e79e3d994937861d94277f3d24b8/1a3c32dcdcc04ef8bcb0e505743f6c57.jpg, createdBy=73805409111, createdName=ms9000000194445124, createdTime=Fri Dec 18 09:38:36 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043433, encodeId=3a61104343309, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Dec 17 15:16:16 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1989602, encodeId=20f3198960245, content=<a href='/topic/show?id=5e202543023' target=_blank style='color:#2F92EE;'>#代谢性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25430, encryptionId=5e202543023, topicName=代谢性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Fri Sep 24 08:16:16 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758869, encodeId=d45f1e5886986, content=<a href='/topic/show?id=9fb76191944' target=_blank style='color:#2F92EE;'>#标准化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61919, encryptionId=9fb76191944, topicName=标准化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86337383877, createdName=108807375_62823139, createdTime=Tue Aug 10 19:16:16 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931717, encodeId=c0c51931e17df, content=<a href='/topic/show?id=1a76e6753b9' target=_blank style='color:#2F92EE;'>#糖尿病管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76753, encryptionId=1a76e6753b9, topicName=糖尿病管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Thu May 13 20:16:16 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797208, encodeId=4efd1e97208b1, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Apr 14 22:16:16 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274352, encodeId=6c8112e4352f1, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335762, encodeId=a2061335e62f9, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438109, encodeId=5670143810951, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463103, encodeId=796e14631036b, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909059, encodeId=fa1a909059ef, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201216/acc2e79e3d994937861d94277f3d24b8/1a3c32dcdcc04ef8bcb0e505743f6c57.jpg, createdBy=73805409111, createdName=ms9000000194445124, createdTime=Fri Dec 18 09:38:36 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043433, encodeId=3a61104343309, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Dec 17 15:16:16 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1989602, encodeId=20f3198960245, content=<a href='/topic/show?id=5e202543023' target=_blank style='color:#2F92EE;'>#代谢性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25430, encryptionId=5e202543023, topicName=代谢性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Fri Sep 24 08:16:16 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758869, encodeId=d45f1e5886986, content=<a href='/topic/show?id=9fb76191944' target=_blank style='color:#2F92EE;'>#标准化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61919, encryptionId=9fb76191944, topicName=标准化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86337383877, createdName=108807375_62823139, createdTime=Tue Aug 10 19:16:16 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931717, encodeId=c0c51931e17df, content=<a href='/topic/show?id=1a76e6753b9' target=_blank style='color:#2F92EE;'>#糖尿病管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76753, encryptionId=1a76e6753b9, topicName=糖尿病管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Thu May 13 20:16:16 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797208, encodeId=4efd1e97208b1, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Apr 14 22:16:16 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274352, encodeId=6c8112e4352f1, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335762, encodeId=a2061335e62f9, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438109, encodeId=5670143810951, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463103, encodeId=796e14631036b, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909059, encodeId=fa1a909059ef, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201216/acc2e79e3d994937861d94277f3d24b8/1a3c32dcdcc04ef8bcb0e505743f6c57.jpg, createdBy=73805409111, createdName=ms9000000194445124, createdTime=Fri Dec 18 09:38:36 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043433, encodeId=3a61104343309, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Dec 17 15:16:16 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1989602, encodeId=20f3198960245, content=<a href='/topic/show?id=5e202543023' target=_blank style='color:#2F92EE;'>#代谢性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25430, encryptionId=5e202543023, topicName=代谢性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Fri Sep 24 08:16:16 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758869, encodeId=d45f1e5886986, content=<a href='/topic/show?id=9fb76191944' target=_blank style='color:#2F92EE;'>#标准化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61919, encryptionId=9fb76191944, topicName=标准化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86337383877, createdName=108807375_62823139, createdTime=Tue Aug 10 19:16:16 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931717, encodeId=c0c51931e17df, content=<a href='/topic/show?id=1a76e6753b9' target=_blank style='color:#2F92EE;'>#糖尿病管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76753, encryptionId=1a76e6753b9, topicName=糖尿病管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Thu May 13 20:16:16 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797208, encodeId=4efd1e97208b1, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Apr 14 22:16:16 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274352, encodeId=6c8112e4352f1, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335762, encodeId=a2061335e62f9, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438109, encodeId=5670143810951, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463103, encodeId=796e14631036b, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909059, encodeId=fa1a909059ef, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201216/acc2e79e3d994937861d94277f3d24b8/1a3c32dcdcc04ef8bcb0e505743f6c57.jpg, createdBy=73805409111, createdName=ms9000000194445124, createdTime=Fri Dec 18 09:38:36 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043433, encodeId=3a61104343309, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Dec 17 15:16:16 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=1989602, encodeId=20f3198960245, content=<a href='/topic/show?id=5e202543023' target=_blank style='color:#2F92EE;'>#代谢性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25430, encryptionId=5e202543023, topicName=代谢性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Fri Sep 24 08:16:16 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758869, encodeId=d45f1e5886986, content=<a href='/topic/show?id=9fb76191944' target=_blank style='color:#2F92EE;'>#标准化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61919, encryptionId=9fb76191944, topicName=标准化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86337383877, createdName=108807375_62823139, createdTime=Tue Aug 10 19:16:16 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931717, encodeId=c0c51931e17df, content=<a href='/topic/show?id=1a76e6753b9' target=_blank style='color:#2F92EE;'>#糖尿病管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76753, encryptionId=1a76e6753b9, topicName=糖尿病管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Thu May 13 20:16:16 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797208, encodeId=4efd1e97208b1, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Apr 14 22:16:16 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274352, encodeId=6c8112e4352f1, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335762, encodeId=a2061335e62f9, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438109, encodeId=5670143810951, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463103, encodeId=796e14631036b, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909059, encodeId=fa1a909059ef, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201216/acc2e79e3d994937861d94277f3d24b8/1a3c32dcdcc04ef8bcb0e505743f6c57.jpg, createdBy=73805409111, createdName=ms9000000194445124, createdTime=Fri Dec 18 09:38:36 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043433, encodeId=3a61104343309, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Dec 17 15:16:16 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2020-12-18 ms9000000194445124

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1989602, encodeId=20f3198960245, content=<a href='/topic/show?id=5e202543023' target=_blank style='color:#2F92EE;'>#代谢性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25430, encryptionId=5e202543023, topicName=代谢性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Fri Sep 24 08:16:16 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758869, encodeId=d45f1e5886986, content=<a href='/topic/show?id=9fb76191944' target=_blank style='color:#2F92EE;'>#标准化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61919, encryptionId=9fb76191944, topicName=标准化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86337383877, createdName=108807375_62823139, createdTime=Tue Aug 10 19:16:16 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931717, encodeId=c0c51931e17df, content=<a href='/topic/show?id=1a76e6753b9' target=_blank style='color:#2F92EE;'>#糖尿病管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76753, encryptionId=1a76e6753b9, topicName=糖尿病管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Thu May 13 20:16:16 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797208, encodeId=4efd1e97208b1, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Apr 14 22:16:16 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274352, encodeId=6c8112e4352f1, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335762, encodeId=a2061335e62f9, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438109, encodeId=5670143810951, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463103, encodeId=796e14631036b, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Sat Dec 19 03:16:16 CST 2020, time=2020-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909059, encodeId=fa1a909059ef, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201216/acc2e79e3d994937861d94277f3d24b8/1a3c32dcdcc04ef8bcb0e505743f6c57.jpg, createdBy=73805409111, createdName=ms9000000194445124, createdTime=Fri Dec 18 09:38:36 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043433, encodeId=3a61104343309, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Dec 17 15:16:16 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2020-12-17 misszhang

    谢谢MedSci提供最新的资讯

    0

相关资讯

Diabetes care:强化治疗可减少1型糖尿病患者长期并发症

研究要点: DCCT/EDIC研究探讨强化治疗是否可以预防或延缓1型糖尿病患者长期并发症;发现强化治疗可降低1型糖尿病患者长期并发症,并能改善患者预期健康寿命。 糖尿病控制与并发症研究(DCCT)旨在验证“血糖假说“,并确定1型糖尿病(T1DM)并发症是否可以被预防或延缓。DCCT后继的观察性糖尿病干预及并发症的流行病学(EDIC)研究进一步确定DCCT研究的持久性,对更严重糖尿病

Diabetes Care:有效的服药依从性自我报告利于2型糖尿病管理

  来自美国的一项研究结果,支持易于管理的自我报告对改善糖尿病患者服药依从性的有效性。在1个月内,按百分比计算评级的服药依从性,与药物事件监视系统(MEMS)和糖化血红蛋白之(HbA1c)间显示最强的关联;而在那些需要报告错误剂量的受试者中,有较弱的关联。为期一周、要求受访者记录错误剂量数量的自我评价和测量,表现为易于受到抑郁症严重程度的影响而产生偏差。研究在2012年11月30日在线发表于《糖尿

纪立农:做糖尿病管理 首先应考虑如何降低早死率

全球流行病学的数据显示,由主要慢性非传染性疾病(肿瘤、心血管疾病、糖尿病和慢性呼吸系统疾病)导致的过早死亡(定义为30岁~70岁间死亡),占人类过早死亡的80%左右。减少这些疾病所导致的过早死亡是提高人群预期寿命的主要途径。那么我们目前面临着怎样的慢病管理的现状以及如何更好地进行慢病管理?本期,特邀北京大学糖尿病中心、北京大学人民医院内分泌科主任纪立农为我们介绍如何通过慢病管理来助力实现健康中国的

血糖波动为糖尿病管理新焦点1

      李玉秀         在社会高速发展的今天,糖尿病已成为一种危害人类健康的公众疾病,而由它引起的各种并发症也慢慢侵蚀着人们的生活。作为代谢性疾病之一,糖尿病患者的糖代谢紊乱特点主要表现为长期慢性高血糖、短期血糖波动以及低血糖发作。对于并发症的发生和发展,以上三个因素的影响孰轻孰重,目前仍有争议。持续高血糖的危害已有大量流行病学和病理生理学研究证实,而血糖波动

Diabetic Medicine:随着时间的推移,1型糖尿病患者的糖尿病困扰与糖尿病管理恶化有关

近日,国际杂志 《Diabetic Medicine》上在线发表一项根据德国健康保险数据进行分析的研究,发现关于尽管有新的药物,2型糖尿病患者严重低血糖发生率有所增加。通过分析比较2006年和2011年与药物相关的严重低血糖发生率,评估提供有效血糖控制同时降低低血糖风险的新抗高血糖药物的使用。

Nat Commun:合成基因回路或助人轻松管理糖尿病

英国《自然·通讯》杂志 19 日 发表 一项合成生物学新进展:欧洲科学家团队设计出了一种全新合成生物学基因回路,并证明可以通过咖啡因激活这种合成基因回路。小鼠糖尿病模型研究显示,其可以成功调节血糖水平。该研究成果或将助力人类对抗糖尿病,同时亦展示了合成生物学在医疗界的应用潜力。